Evidence map›Paper›PMID 38425352›Full record

ArticleCurrent journal of neurology2023

Neuro-mucormycosis: Lessons from COVID-19-associated cases.

Nahad Sedaghat, Masoud Etemadifar, Pouria Ghasemi, Mohammad Naghizadeh, Yousef Mokari, Mehri Salari, Bahar Golastani

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current journal of neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 75% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Nahad SedaghatAlzahra Research Institute, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.
Masoud EtemadifarDepartment of Neurosurgery, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Pouria GhasemiAlzahra Research Institute, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.
Mohammad NaghizadehAlzahra Research Institute, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.
Yousef MokariSchool of Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Mehri SalariFunctional Neurosurgery Research Center, Shohada Tajrish Comprehensive Neurosurgical Center of Excellence, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Bahar GolastaniDepartment of Cell and Molecular Biology and Microbiology, School of Biological Science and Technology, University of Isfahan, Isfahan, Iran.
Isfahan University of Medical Sciences · IRAlzahra University · IRShahid Beheshti University of Medical Sciences · IRShahrekord University of Medical Sciences · IRUniversity of Isfahan · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Case-Control StudiesCOVID-19MucormycosisNeurological ManifestationsSARS-CoV-2

Identifiers

PMID38425352
PMCPMC10899533
OpenAlexW4390237012

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.